Structure-based computational investigation of potential TarA inhibitors in Staphylococcus aureus

Boggarapu Ganesh1, Lalitha Guruprasad2

  • 1School of Chemistry, University of Hyderabad, Hyderabad, 500046, India.

Molecular Diversity
|February 25, 2026
PubMed

Insights

Novel drug candidates targeting Staphylococcus aureus TarA were identified. These compounds show potential for developing new therapies against antibiotic-resistant bacterial infections by disrupting cell wall synthesis.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Staphylococcus aureus poses a significant health threat due to antibiotic resistance.
  • Wall teichoic acids (WTAs) are essential for Gram-positive bacterial survival, making their biosynthesis pathway a promising drug target.
  • TarA is a critical enzyme initiating WTA precursor synthesis, making it a key target for therapeutic intervention.

Purpose of the Study:

  • To identify novel compounds that inhibit the essential S. aureus TarA enzyme.
  • To explore the potential of TarA as a drug target for combating antibiotic-resistant S. aureus infections.

Main Methods:

  • Obtained the 3D structure of S. aureus TarA using AlphaFold2.
  • Performed virtual screening and molecular docking to identify potential hit compounds.
  • Conducted molecular dynamics simulations to analyze the binding interactions and stability of TarA-compound complexes.

Main Results:

  • Identified several hit compounds with significant binding affinity to the S. aureus TarA domain.
  • Key amino acid residue interactions were elucidated, crucial for TarA inhibition.
  • Molecular dynamics simulations confirmed the stability and binding efficacy of the identified hit molecules.

Conclusions:

  • The S. aureus TarA protein is a viable drug target for developing new antibacterial agents.
  • The identified hit molecules represent promising leads for novel therapeutic strategies against S. aureus infections.
  • Further development of these compounds could lead to effective treatments for antibiotic-resistant S. aureus.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...